← Eichor
Condition: Skin And Subcutaneous Tissue Disorders Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Skin And Subcutaneous Tissue Disorders

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown O
Phase 3 · 93 location(s) · Sanofi · NCT05263206Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.
EARLY_Phase 1 · 1 location(s) · University of Alabama at Birmingham · NCT06326476Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer
NA · 9 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT07095023A First-in-human Study of KT502 in Adult Participants With Rheumatoid Arthritis (RA)
Phase 1 · 2 location(s) · Kali Therapeutics, Inc. · NCT07564154NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine Care
Phase N/A · 16 location(s) · AstraZeneca · NCT07424261Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Even
Phase 3 · 47 location(s) · AbbVie · NCT05609630A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Sub
Phase 1 · 10 location(s) · AbbVie · NCT07607964Efficacy of Neoadjuvant Subcutaneous Trastuzumab-Pertuzumab in Algerian Women With Locally Advanced HER2 Positive Breast
Phase N/A · 1 location(s) · Blida 1 University · NCT07166185Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
Phase 2 · 16 location(s) · Oneness Biotech Co., Ltd. · NCT06397911Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study
Phase 2 · 8 location(s) · University Hospital, Limoges · NCT03582800A Clinical Study to Evaluate SM17 for Atopic Dermatitis
Phase 2 · 1 location(s) · SinoMab BioScience Ltd · NCT07445919Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Phase 3 · 139 location(s) · MoonLake Immunotherapeutics AG · NCT06641089Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Phase 3 · 7 location(s) · Chiesi Farmaceutici S.p.A. · NCT06679270A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Sys
Phase 3 · 103 location(s) · AstraZeneca · NCT07430306A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYP
Phase 2 · 32 location(s) · Sanofi · NCT02991469Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Phase 1/Phase 2 · 6 location(s) · Simcha IL-18, Inc. · NCT04787042A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in
Phase 3 · 150 location(s) · Sanofi · NCT06241118Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access an
Phase 2 · 1 location(s) · Mayo Clinic · NCT06265285A First-in-human Study of KT501 Administered Subcutaneously to Patients With Rheumatoid Arthritis (RA).
Phase 1 · 1 location(s) · Kali Therapeutics, Inc. · NCT07234773Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Ca
NA · 2 location(s) · Hospital Arnau de Vilanova · NCT06770374Changes in MTX-PG Concentrations During Subcutaneous MTX Therapy in Patients With Rheumatoid Arthritis(COSMOS Study)
Phase 4 · 1 location(s) · Keio University · NCT06913907Multimodal Ultrasound for Differentiating Lymphedema and Lipedema
Phase N/A · 1 location(s) · Kayseri City Hospital · NCT07489248Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
Phase 2 · 1 location(s) · Diwakar Davar · NCT07223424A Phase 1 Clinical Study Comparing GS101 and Dupixent® After Subcutaneous Injection
Phase 1 · 1 location(s) · Jiangsu Genscend Biopharmaceutical Co., Ltd · NCT07411755Ultrasonographic Patterns and Pathological Correlation in the Diagnosis of Subcutaneous Nodules
NA · 1 location(s) · Mahidol University · NCT06838988A Phase I Study to Assess LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus
Phase 1 · 11 location(s) · Nanjing Leads Biolabs Co.,Ltd · NCT07323173A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy Subjects
Phase 1 · 1 location(s) · Suzhou Suncadia Biopharmaceuticals Co., Ltd. · NCT07414602Assessment of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of Ge
Phase 1 · 1 location(s) · Changchun GeneScience Pharmaceutical Co., Ltd. · NCT07040930A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in
Phase 3 · 148 location(s) · AbbVie · NCT06461897Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma.
Phase 2 · 7 location(s) · University Hospital, Toulouse · NCT04356755
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.